MobileODT For Profit
A complete diagnostics and treatment solution for cervical cancer, including EVA Pro digital colposcope with a built-in camera and advanced software applications, Delphi HPV 16/18/31/33/45/52/58 Antigen Rapid test with no lab needed, and ThermoGlide thermocoagulation treatment for precancerous lesions.
Funding Status:
Late Stage Venture
Industry:
Clinical Data Management
Estimated Revenue:
$2Mper year
Technology:
Biomarker panels
Number Of Exists:
N/A
Headquarters:
Tel Aviv, Tel Aviv, Israel
Total Funding:
14130000
Last Funding Date:
2020-08-12
Last Funding Type:
Series C
Investor Type:
N/A
Employee Number:
11-50
Investors Number:
9
Investment Stage:
N/A
Founded Date:
2012-10-01